Previous studies investigating expression levels ofSNHG9 and GAS5 showed inversed correlation in clear cellrenal cell carcinoma (Yang et al., 2020) and glioblastoma (Ji etal., 2020), but no common regulation mechanism was suggested.To the best of our knowledge, such correlation betweenSNHG9 and GAS5 has never been described before in studiesof metabolic disorders. This evidence concerns the gene GAS5 and metabolic disease.